Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) subsidiary Guanghua Pharmaceutical received Macau drug registration certificate.

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings Guanghua Pharmaceutical Co., Ltd. (referred to as "Guanghua Pharmaceuticals"), recently received a "Certificate of Registration of Traditional Chinese Medicine" from the Macao Special Administrative Region Government Pharmaceutical Supervision and Administration Bureau for the drug named Xiaochaihu Granules (sugar-free type) [Guangzhou Baiyunshan Pharmaceutical Holdings]. It is reported that Xiaochaihu Granules are used for dispersing exterior pathogenic factors, regulating liver and stomach, and treating diseases caused by external factors invading the Shaoyang meridian. Symptoms include alternating chills and fever, fullness and discomfort in the chest and hypochondrium, loss of appetite, irritability with nausea, bitterness in the mouth, and dry throat.